DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute
Aug 03, 2020, at 11:13 pm
New Delhi: The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.
Study paves the way for new autoimmune disease treatments with fewer side effects
Nov 04, 2016, at 08:53 pm
London, Nov 4 (IBNS): A research team has been using genetics to explore ways of producing new treatments for autoimmune diseases, but with significantly fewer side effects.
'Clocks' in tree-rings that could reset chronologies across the ancient world, says study
Aug 18, 2016, at 02:39 am
London, Aug 17 (IBNS): Oxford University researchers say that trees which grew during intense radiation bursts in the past have 'time-markers' in their tree-rings that could help archaeologists date events from thousands of years ago.